62. Molecular profile of patients with Acute Myeloid Leukemia at diagnosis

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

Paulo Campregher Paulo Campregher, MD, PhD is a hematologist and molecular pathologist in charge of cancer genomics assays in solid tumors and hematology at Hospital Israelita Albert Einstein, São Paulo, Brazil. He is also a professor at Health Sciences Graduate...

63. Comparative analysis of testing methods used for the detection of internal tandem duplications in the KMT2A/MLL gene

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

José-Mario Capo-Chichi Dr Capo-Chichi is a lab director at the Genome Diagnostics Laboratory at University Health Network (UHN) in Toronto and an assistant professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Dr Capo-Chichi...

73. Chromosomal microarray-based genomic profiling of T-cell Large Granular Lymphocyte Leukemia

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

Jinbo Fan Director of clinical cytogenetics Lab, co-director of clinical genomics Lab, associate director of AP/CP residency training program in the Department of Pathology at University of Virginia Abstract Jinbo Fan, Lei Wang, Eli Williams University of Virginia,...

78. Identification of a non-productive KMT2A rearrangement in B-ALL with apparent concurrent ETV6::RUNX1 and KMT2A fusions

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

Marie-France Gagnon Marie-France Gagnon received her MD at the University of Montreal. Subsequently, she completed her Medicine residency and Hematology fellowship at the University of Montreal. She also holds a master’s degree in biomedical sciences focusing on the...

80. Evaluation of MYEOV expression in multiple myeloma patients with IGH::CCND1 rearrangement and chromosome 11 polysomy.

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

Shivani Golem Dr. Golem is the medical director of Cytogenetics at the University of Kansas Medical Center and the University of Kansas Health System. She is dual boarded in Laboratory Genetics and Genomics, and Clinical Cytogenetics and Genomics. She...

81. Discrepancies in the detection of PML::RARA gene rearrangement by FISH using commonly used dual-color dual-fusion probes

by achatfield@ezav.biz | Jul 20, 2022 | 1 - Hematologic Malignancies

Shivani Golem Dr. Golem is the medical director of Cytogenetics at the University of Kansas Medical Center and the University of Kansas Health System. She is dual boarded in Laboratory Genetics and Genomics, and Clinical Cytogenetics and Genomics. She...